These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 124237)

  • 21. The bioavailability of isoniazid, rifampin, and pyrazinamide in two commercially available combined formulations designed for use in the short-course treatment of tuberculosis.
    Ellard GA; Ellard DR; Allen BW; Girling DJ; Nunn AJ; Teo SK; Tan TH; Ng HK; Chan SL
    Am Rev Respir Dis; 1986 Jun; 133(6):1076-80. PubMed ID: 3717760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isoniazid acetylation rates (phenotypes) of patients being treated for tuberculosis.
    Mason E; Russell DW
    Bull World Health Organ; 1971; 45(5):617-24. PubMed ID: 5316954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The determination of isoniazid and its metabolites acetylisoniazid, monoacetylhydrazine, diacetylhydrazine, isonicotinic acid and isonicotinylglycine in serum and urine.
    Ellard GA; Gammon PT; Wallace SM
    Biochem J; 1972 Feb; 126(3):449-58. PubMed ID: 5075259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [HPLC study of blood isoniazid in patients with tuberculosis in Tunisia: significance and therapeutic results].
    Barhoumi C; Masmoudi AS; Gritli N; Hamza M; Nsiri B; Amor A; Mechghoul S; Belhadj O
    Tunis Med; 1995 Oct; 73(10):379-84. PubMed ID: 9506162
    [No Abstract]   [Full Text] [Related]  

  • 25. [Administration by slow phleboclysis of isoniazid and para-aminosalicylic acid in the treatment of tuberculosis. Therapeutic effects and blood levels of the drug].
    Mariani B; Bisetti A; Monzali G
    G Ital Mal Torace; 1967; 21(2):81-92. PubMed ID: 5602966
    [No Abstract]   [Full Text] [Related]  

  • 26. [Concentration and tolerance of INH and PAS in single daily doses. (Preliminary report)].
    Vil'derman AM; Finn ER; Busygina RN; Draganiuk KA; Ezerskiĭ VF; Evgrafova ZA
    Probl Tuberk; 1965; 43(11):30-4. PubMed ID: 5875728
    [No Abstract]   [Full Text] [Related]  

  • 27. [Antibacterian activity modifications of serum isoniazid when using it with rifampicin (author's transl)].
    Nouhouayi A; Bergogne-Berezin E; Lafaix C
    Pathol Biol (Paris); 1982 Jun; 30(6):389-93. PubMed ID: 7050848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Universal microbiological method of determination of concentration in the blood of individual antibacterial preparations in their combined therapeutic use in the patients].
    Rudoĭ NM; Utkin VV
    Lab Delo; 1969; 6():360-3. PubMed ID: 4185841
    [No Abstract]   [Full Text] [Related]  

  • 29. Quantitative estimation of isonicotinic acid hydraizide and p-aminosalicylic acid in blood serum.
    LEIFHEIT HC; SMITH ER
    Am J Clin Pathol; 1959 Feb; 31(2):142-7. PubMed ID: 13626903
    [No Abstract]   [Full Text] [Related]  

  • 30. Rapid determination of isonicotinic acid hydrazide in whole blood with 2,4,6-trinitrobenzenesulphonic acid.
    Dymond LC; Russell DW
    Clin Chim Acta; 1970 Mar; 27(3):513-20. PubMed ID: 5435232
    [No Abstract]   [Full Text] [Related]  

  • 31. [Change in isoniazid-H3 concentration in the blood and tissues in relation to dosage and mode of administration].
    Bondarev IM; Azhipa IaI; Cherednichenko LP
    Biull Eksp Biol Med; 1970 Oct; 70(10):31-4. PubMed ID: 5493115
    [No Abstract]   [Full Text] [Related]  

  • 32. Absorption of ethionamid, isoniazid, and aminosalicylic acid from the post-resection gastrointestinal tract.
    Mattila MJ; Friman A; Larmi TK; Koskinen R
    Ann Med Exp Biol Fenn; 1969; 47(3):209-12. PubMed ID: 5367517
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of insulin on isoniazid and para-aminosalicylic acid metabolism in patients with pulmonary tuberculosis].
    Savula MM; Kiselova ES
    Probl Tuberk; 1974; (8):43-6. PubMed ID: 4409368
    [No Abstract]   [Full Text] [Related]  

  • 34. [Blood bacteriostatic activity in patients depending on the type of inactivation of isonicotinic acid hydrazide in the body].
    Gil'madinova RSh; Bakanova DIa
    Antibiotiki; 1971 Jan; 16(1):87-90. PubMed ID: 4994900
    [No Abstract]   [Full Text] [Related]  

  • 35. [Levels of isonicotinic acid amide in patients with pulmonary tuberculosis treated with isonicotinic acid hydrazide and ethionamide].
    Sosnowski W; Rozniecki J; Podoska M; Galamon T
    Gruzlica; 1970 Oct; 38(11):1089-95. PubMed ID: 4249764
    [No Abstract]   [Full Text] [Related]  

  • 36. [THE ROLE OF ACETYLATION IN THE EFFECTIVENESS OF TREATMENT WITH COMBINED ISONIAZID AND PARA-AMINOSALICYLIC ACID, AND ISONIAZID WITH PARA-AMINOBENZOIC ACID, IN PULMONARY TUBERCULOSIS].
    VITOLO A
    Bull Sci Med (Bologna); 1963; 135():396-402. PubMed ID: 14112984
    [No Abstract]   [Full Text] [Related]  

  • 37. Modification of the serum isoniazid levels by different preparations of paraaminosalicylic acid.
    Tiitinen H; Mattila MJ
    Arzneimittelforschung; 1968 May; 18(5):623-5. PubMed ID: 5755895
    [No Abstract]   [Full Text] [Related]  

  • 38. [Blood concentration of basic tuberculostatic preparations with single administration of daily doses in pulmonary tuberculosis].
    Kanevskaia SS
    Probl Tuberk; 1970; 48(10):54-8. PubMed ID: 5496751
    [No Abstract]   [Full Text] [Related]  

  • 39. Acetylator phenotyping of tuberculosis patients using matrix isoniazid or sulphadimidine and its prognostic significance for treatment with several intermittent isoniazid-containing regimens.
    Ellard GA; Gammon PT
    Br J Clin Pharmacol; 1977 Feb; 4(1):5-14. PubMed ID: 843424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Inactivation of isonicotinic acid hydrazides in the organism of patients and drug resistance of Mycobacterium tuberculosis].
    Vil'derman AM; Finn ER; Evgrafova ZA
    Probl Tuberk; 1965; 43(8):72-5. PubMed ID: 5869069
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.